Maintenance Notice (3:00 AM - 8:30 AM December 13, 10:30 PM December 13 - 12:40 AM December 14 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.200 | Product Document Searching Made Easy by 2D Code! | TCI Life Science News December 2025 | [Product Highlights] Catechol-containing Methacrylate Monomer for... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 144875-48-9 | 產品號碼: R0197
補充產品訊息:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| 產品號碼 | R0197 |
純度/分析方法 
|
>98.0%(HPLC) |
| 分子式 / 分子量 | C__1__7H__2__2N__4O__2 = 314.39 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件
|
Frozen (-20°C) |
| 儲存在惰性氣體下 | Store under inert gas |
| 應避免的情況 | Hygroscopic,Heat Sensitive |
| 包裝和容器
|
100MG-Glass Bottle with Plastic Insert （閲覽圖片）, 25MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 144875-48-9 |
| Reaxys-RN | 9792901 |
| PubChem Substance ID | 354335079 |
| Merck Index(14) | 8151 |
| MDL編號 | MFCD00937759 |
產品規格
| Appearance | White to Light yellow to Light orange powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
性質
| 熔點 | 193 °C |
| Maximum Wavelength | 325 nm |
GHS
相關法規
| RTECS # | NJ5911320 |
運輸資料
| HS編碼* | 2933.99-000 |
Application
Resiquimod: A Toll-Like Receptor Agonist
Resiquimod (R-848) is a tricyclic imidazoquinolone compound and an imiquimod [I0747] analog. Toll-like receptors (TLRs) play an important role in the innate immune response to pathogens. Reportedly, resiquimod act as an immunomodulator and an anti-viral agent through activation immune cells via the Toll-like receptor 7 and 7/8 (TLR7 and TLR7/8) dependent signaling pathway. And then, resiquimod induces mRNA encoding cytokines including interferon-α (INF-α) at the treatment site. (The product is for research purpose only.)
References
- Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
- Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
- Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
- The antiviral activity of toll-like receptor 7 and 7/8 agonists (a review)
- The use of Toll-like receptor 7/8 agonists as vaccine adjuvants (a review)
PubMed Literature
文檔
產品介紹報導
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。